Manufacturer copay assistance · Trodelvy (J9317) · Gilead Sciences
$0/dose · Maximum benefit Up to $25,000 per calendar year · Covers Trodelvy drug cost only — patient is responsible for cost-share of treatments and office visits
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Trodelvy — the program's cap applies against the patient share CareCost calculates.
Yes — Gilead Oncology Co-Pay Program from Gilead Sciences. Eligible patients may pay as little as $0 out of pocket for Trodelvy. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients may pay as little as $0 out of pocket for Trodelvy Maximum benefit: Up to $25,000 per calendar year. Covers Trodelvy drug cost only — patient is responsible for cost-share of treatments and office visits
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.